Injective is projected to rise to $8.89 by 2027, a +58% move from its current price of $5.44. INJ is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy. Market sentiment sits at 22/100 (Extreme Fear) on the Fear & Greed Index.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via CoinGecko & CoinMarketCap · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $5.14 | $5.45 | $5.78 | +0.18% |
| May 30 | $5.02 | $5.46 | $5.93 | +0.35% |
| May 31 | $4.94 | $5.47 | $6.06 | +0.53% |
| Jun 1 | $4.87 | $5.48 | $6.16 | +0.70% |
| Jun 2 | $4.81 | $5.49 | $6.26 | +0.88% |
| Jun 3 | $4.76 | $5.50 | $6.35 | +1.06% |
| Jun 4 | $4.71 | $5.51 | $6.43 | +1.24% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.71 | $5.51 | $6.43 | +1.24% |
| Week 2 | $4.47 | $5.58 | $6.95 | +2.49% |
| Week 3 | $4.31 | $5.64 | $7.39 | +3.75% |
| Week 4 | $4.19 | $5.71 | $7.80 | +5.03% |
| Week 5 | $4.08 | $5.78 | $8.19 | +6.33% |
| Week 6 | $4.00 | $5.86 | $8.57 | +7.64% |
| Week 7 | $3.93 | $5.93 | $8.95 | +8.97% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Injective is an interoperable Layer 1 blockchain designed for DeFi applications. It provides developers with on-chain financial infrastructure modules to build dApps such as decentralized exchanges, prediction markets, and lending protocols. Its decentralized cross-chain bridging infrastructure offers compatibility with most blockchains, including EVM chains like Ethereum and non-EVM chains like Solana.
Injective operates as a Layer 1 smart contract platform focused on DeFi, enabling on-chain infrastructure for a range of decentralized finance applications. The cross-chain bridging capability connects it with multiple ecosystems, supporting interoperability across chains used in the broader crypto landscape.
In category terms, Injective is positioned within the Layer 1 and DeFi spaces, reflecting its role as an interoperable base layer for building cross-chain financial apps and services.
Injective (INJ) is currently trading at $5.63 with a market cap of $560.2M and ranks 95th. The asset has an all‑time high of $52.62 and an all‑time low of $0.6574, illustrating a wide historical range.
The price outlook shows a neutral start in 2026 with an average near the current level ($5.63) and no expected change in the 2026 forecast (min $2.74, avg $5.63, max $5.63; ROI 0%; sentiment NEUTRAL). From 2027 onward, the forecast envisions substantial upside, with 2027 averaging $8.89 and a max of $13.39 (ROI 58%, sentiment BULLISH).
Longer term, the forecast projects continued growth with 2028 averaging $18.01 (max $28.81, ROI 219.8%), 2029 averaging $24.00 (max $40.27, ROI 326.3%), and 2030 averaging $26.90 (max $46.95, ROI 377.8%). The trajectory extends to multi-year highs, with 2040 averaging $157.02 and 2050 averaging $669.21, reflecting very large potential upside (ROIs of 2689% and 11786.5% respectively) and a bullish overall tone.
A major floor 50.6% below — a decisive break under it would weaken the trend.
The nearest floor, 37.1% below — buyers have tended to step in here.
The nearest ceiling, 3.5% above — a clean break opens room to run.
A major ceiling 30.5% above — clearing it would confirm fresh momentum.
Key INJ support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of INJ market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.33 | Buy | $5.30 | Buy |
| MA 10 | $5.08 | Buy | $5.13 | Buy |
| MA 20 | $4.79 | Buy | $4.80 | Buy |
| MA 50 | $3.91 | Buy | $4.19 | Buy |
| MA 100 | $3.48 | Buy | $4.05 | Buy |
| MA 200 | $4.28 | Buy | $5.06 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 67.30 | Neutral |
| Stoch RSI (14) | 29.03 | Neutral |
| CCI (20) | 138.74 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | 9.39 | Buy |
| Bollinger %B (20,2) | 0.93 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 1.48 | Buy |
| Awesome (5,34) | 1.04 | Buy |
| Ultimate (7,14,28) | 63.71 | Neutral |
| Momentum (10) | 0.73 | Buy |
| Aroon Osc (25) | 100.00 | Buy |
| Hull MA (9) | 5.39 | Buy |
| ADX (14) | 33.29 | Buy |
| ATR (14) | 0.23 | Info |
The 14-day momentum is bullish, with RSI(14) at 70, suggesting upside pressure but approaching overbought conditions. The near-term trend is supported by a 50-day simple moving average of $3.91 and a 200-day simple moving average of $4.28, placing the current price above both moving averages.
Near-term support sits at $3.42, while resistance is at $5.63. The 30-day price range runs from a low of $4.08 to a high of $7.77, indicating notable volatility within the month and the potential for a test of resistance levels above the current price.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.74 | $5.63 | $5.63 | 0% | Neutral | |
| $6.39 | $8.89 | $13.39 | +58% | Bullish | |
| $12.20 | $18.01 | $28.81 | +220% | Bullish | |
| $15.44 | $24.00 | $40.27 | +326% | Bullish | |
| $16.51 | $26.90 | $46.95 | +378% | Bullish | |
| $12.07 | $20.55 | $37.11 | +265% | Bullish | |
| $29.30 | $52.02 | $96.82 | +824% | Bullish | |
| $44.17 | $81.67 | $156.18 | +13.5x | Bullish | |
| $38.81 | $74.65 | $146.33 | +12.3x | Bullish | |
| $36.99 | $73.95 | $148.30 | +12.1x | Bullish | |
| $70.66 | $157.02 | $345.85 | +26.9x | Bullish | |
| $301.14 | $669.21 | $1,539.18 | +117.9x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $2.74 | $5.63 | $6.87 | +3.49% |
| June 2026 | $5.51 | $6.61 | $8.24 | +17.47% |
| July 2026 | $5.23 | $6.38 | $8.15 | -3.47% |
| August 2026 | $4.25 | $5.26 | $6.85 | -17.57% |
| September 2026 | $4.16 | $5.20 | $6.87 | -1.21% |
| October 2026 | $4.28 | $5.41 | $7.25 | +4.11% |
| November 2026 | $3.50 | $4.46 | $6.05 | -17.64% |
| December 2026 | $3.04 | $3.91 | $5.36 | -12.39% |
Click any year to see its month-by-month INJ forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Injective's 2026 outlook centres on $5.63, within a $2.74 to $5.63 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, INJ could reach as high as $13.39, with a base case around $8.89 and support toward $6.39 — roughly +58% from $5.44. Buyers look set to stay in control over this stretch.
Expect INJ to range from $12.20 to $28.81 through 2028. The $18.01 average target implies a +220% move from current prices. That is up +102% on the projected 2027 average. Momentum favours further upside here.
The INJ price prediction for 2029 points to an average of $24.00 (low $15.44, high $40.27) — a potential gain of +326% on today's $5.44. Buyers look set to stay in control over this stretch.
In 2030, INJ is projected to trade between $16.51 and $46.95, averaging $26.90 — a potential gain of +378% from today's $5.44. That is up +12% on the projected 2029 average. Momentum favours further upside here.
Injective's 2031 outlook centres on $20.55, within a $12.07 to $37.11 range. That is -24% versus the projected 2030 average. That marks a +265% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, INJ could reach as high as $96.82, with a base case around $52.02 and support toward $29.30 — roughly +824% from $5.44. Momentum favours further upside here.
Expect INJ to range from $44.17 to $156.18 through 2033. The $81.67 average target implies a +13.5x move from current prices. That is up +57% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The INJ price prediction for 2034 points to an average of $74.65 (low $38.81, high $146.33) — a potential gain of +12.3x on today's $5.44. Momentum favours further upside here.
In 2035, INJ is projected to trade between $36.99 and $148.30, averaging $73.95 — a potential gain of +12.1x from today's $5.44. That is -1% versus the projected 2034 average. Buyers look set to stay in control over this stretch.
Injective's 2040 outlook centres on $157.02, within a $70.66 to $345.85 range. That is up +112% on the projected 2035 average. That marks a +26.9x change versus current levels. Momentum favours further upside here.
By 2050, INJ could reach as high as $1,539.18, with a base case around $669.21 and support toward $301.14 — roughly +117.9x from $5.44. Buyers look set to stay in control over this stretch.
Investing $1,000 in INJ today (≈ 183.823529 INJ) could be worth
$123,016.36
+$122,016.36 (+12202%) by 2050 · US Dollar
Based on the average projected INJ price of $669.21 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in INJwould be worth at today's price.
$1,000 invested in INJ on May 26, 2025 (≈ 76.198945 INJ) would be worth
$414.52
-$585.48 (-58.5%) today · 0.41× · US Dollar
Based on a INJ entry price of $13.12 vs. today's $5.44.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.12 | $1,062.5 | +6.3% |
| 1 month ago | $3.55 | $1,532.55 | +53.3% |
| 3 months ago | $3.12 | $1,745.03 | +74.5% |
| 6 months ago | $6.02 | $903.93 | -9.6% |
| 1 year ago | $13.12 | $414.52 | -58.5% |
| All time (1.0y) ago | $14.05 | $387.15 | -61.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our INJ forecast.
Our base-case forecast reaches $11.00 around 2028.
Implied market cap at $11.00: $1.1B
Looking further out, the forecast shows a progressive, bullish path with meaningful upside through 2030 and beyond. The average prices rise from $5.63 in 2026 to $8.89 (2037-2027), then to $18.01 (2028) and $24.00 (2029), with 2030 averaging $26.90 and a max of $46.95, yielding a 377.8% ROI.
The trajectory continues with 2031 at $20.55 average and 2032 at $52.02, then 2033 at $81.67 and 2034 at $74.65, all with bullish sentiment. By 2040, the average is projected to $157.02 and by 2050 to $669.21, while the maxs show substantial upside (e.g., 2040 max $345.85 and 2050 max $1,539.18).
These figures point to significant long‑term upside but are estimates, not guarantees, and come with inherent market and execution risk. Investors should consider that sentiment shifts and external factors can influence outcomes.
Tap a question to reveal the answer.
In 2030, the forecast shows a min of $16.51, an avg of $26.90, and a max of $46.95, with a ROI of 377.8% and a bullish sentiment.
The near term starts neutral in 2026 (avg $5.63, min $2.74, max $5.63; ROI 0%) but turns bullish from 2027 onward, with higher avg prices and notable ROIs (e.g., 58% in 2027, 219.8% in 2028, 326.3% in 2029, and 377.8% in 2030). These are estimates and not guarantees.
Yes. The max prices in the forecast exceed $100 in several years, including 2033 (max $156.18) and 2032 (max $96.82) and far beyond in later years, with 2040 (max $345.85) and 2050 (max $1,539.18) showing substantial upside.
Current price is $5.63, market cap is $560.2M, and it ranks 95.
The 30-day range is $4.08 to $7.77, with current price at $5.63. RSI(14) is 70, SMA50 is $3.91, SMA200 is $4.28, with support at $3.42 and resistance at $5.63.
Injective Community Discussion
0Share your Injective price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.